Saroja Pharma In

{
  "main_header": {
    "sid": 10038997,
    "name": "Saroja Pharma In",
    "stock_name": "Saroja Pharma In",
    "full_name": "Saroja Pharma Industries India Ltd",
    "name_url": "stocks-analysis/saroja-pharma-in",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "36.00",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SAROJA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0PCL01011",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 4800,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/saroja-pharma-in-10038997-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Saroja Pharma In falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-saroja-pharma-in-fallingrising-3757873",
        "imagepath": "",
        "date": "2025-12-13 01:24:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>While the stock has delivered a robust one-week return of 9.14%, comfortably outpacing the Sensex’s marginal decline of 0.53% over the same period, the year-to-date performance paints a contrasting picture. Saroja Pharma’s shares have declined by 28.33% since the start of the year, markedly underperforming the Sensex, which has gained 10.16% in that timeframe. Over the past year, the stock has similarly lagged, falling 23.15% against the Sensex’s 6.10% rise. This divergence suggests that despite short-term rallies, the stock remains under pressure from longer-term headwinds.</p>\n<p><strong>Technical Indicators and Investor Participation</strong></p>\n<p>Examining the technical landscape reveals a nuanced scenario. The current price of ₹..."
      },
      {
        "title": "How has been the historical performance of Saroja Pharma In?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-saroja-pharma-in-3699805",
        "imagepath": "",
        "date": "2025-11-13 23:51:10",
        "description": "Answer:\nThe historical performance of Saroja Pharma In shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nSaroja Pharma In's net sales increased from 40.67 Cr in Mar'24 to 53.73 Cr in Mar'25, while total operating income also rose to 53.92 Cr from 40.67 Cr. However, the raw material cost saw a significant increase to 48.28 Cr in Mar'25 from 32.17 Cr in Mar'24. Total expenditure, excluding depreciation, increased to 50.94 Cr in Mar'25 from 38.12 Cr in Mar'24. Operating profit (PBDIT) rose to 2.98 Cr in Mar'25, up from 2.74 Cr in Mar'24, indicating improved operational efficiency despite rising costs. Profit before tax increased to 1.45 Cr in Mar'25 from 1.21 Cr in Mar'24, while profit after tax also grew to 1.03 Cr from 0.88 Cr. The earnings per share (EPS) rose to 2.56 in Mar'25 from 2.19 in Mar'24. On the balance sheet, total assets increased to 39.55 Cr in Mar'25 from 26.56 ..."
      },
      {
        "title": "Why is Saroja Pharma In falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-saroja-pharma-in-fallingrising-3691422",
        "imagepath": "",
        "date": "2025-11-12 00:10:32",
        "description": "As of 11-Nov, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.9 or 4.4%. The stock has underperformed its sector by 4.27% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 66.67% compared to the 5-day average. Over the past week, the stock has decreased by 4.40%, and it has also shown a substantial decline of 31.25% year-to-date, indicating ongoing challenges for the company.\n\nIn the broader market context, while Saroja Pharma's stock has fallen significantly, the benchmark Sensex has shown a slight increase of 0.38% over the past week and a gain of 8.67% year-to-date. This stark contrast highlights the stock's underperformance relative to the market. The overall negative sentim..."
      }
    ],
    "total": 63,
    "sid": "10038997",
    "stock_news_url": "https://www.marketsmojo.com/news/saroja-pharma-industries-india-10038997"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Saroja Pharma In falling/rising?

2025-12-13 01:24:36

Recent Price Movement and Market Context

While the stock has delivered a robust one-week return of 9.14%, comfortably outpacing the Sensex’s marginal decline of 0.53% over the same period, the year-to-date performance paints a contrasting picture. Saroja Pharma’s shares have declined by 28.33% since the start of the year, markedly underperforming the Sensex, which has gained 10.16% in that timeframe. Over the past year, the stock has similarly lagged, falling 23.15% against the Sensex’s 6.10% rise. This divergence suggests that despite short-term rallies, the stock remains under pressure from longer-term headwinds.

Technical Indicators and Investor Participation

Examining the technical landscape reveals a nuanced scenario. The current price of ₹...

Read full news article

How has been the historical performance of Saroja Pharma In?

2025-11-13 23:51:10

Answer: The historical performance of Saroja Pharma In shows fluctuations in key financial metrics over the past four years. Breakdown: Saroja Pharma In's net sales increased from 40.67 Cr in Mar'24 to 53.73 Cr in Mar'25, while total operating income also rose to 53.92 Cr from 40.67 Cr. However, the raw material cost saw a significant increase to 48.28 Cr in Mar'25 from 32.17 Cr in Mar'24. Total expenditure, excluding depreciation, increased to 50.94 Cr in Mar'25 from 38.12 Cr in Mar'24. Operating profit (PBDIT) rose to 2.98 Cr in Mar'25, up from 2.74 Cr in Mar'24, indicating improved operational efficiency despite rising costs. Profit before tax increased to 1.45 Cr in Mar'25 from 1.21 Cr in Mar'24, while profit after tax also grew to 1.03 Cr from 0.88 Cr. The earnings per share (EPS) rose to 2.56 in Mar'25 from 2.19 in Mar'24. On the balance sheet, total assets increased to 39.55 Cr in Mar'25 from 26.56 ...

Read full news article

Why is Saroja Pharma In falling/rising?

2025-11-12 00:10:32

As of 11-Nov, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.9 or 4.4%. The stock has underperformed its sector by 4.27% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 66.67% compared to the 5-day average. Over the past week, the stock has decreased by 4.40%, and it has also shown a substantial decline of 31.25% year-to-date, indicating ongoing challenges for the company. In the broader market context, while Saroja Pharma's stock has fallen significantly, the benchmark Sensex has shown a slight increase of 0.38% over the past week and a gain of 8.67% year-to-date. This stark contrast highlights the stock's underperformance relative to the market. The overall negative sentim...

Read full news article

View All News